MX336736B - Composiciones de derivados de quitina parcialmente desacetilados. - Google Patents
Composiciones de derivados de quitina parcialmente desacetilados.Info
- Publication number
- MX336736B MX336736B MX2007015767A MX2007015767A MX336736B MX 336736 B MX336736 B MX 336736B MX 2007015767 A MX2007015767 A MX 2007015767A MX 2007015767 A MX2007015767 A MX 2007015767A MX 336736 B MX336736 B MX 336736B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- present
- processes
- quitine
- deactilated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 238000000034 method Methods 0.000 abstract 3
- 229920002101 Chitin Polymers 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 239000012620 biological material Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract 1
- 239000001506 calcium phosphate Substances 0.000 abstract 1
- -1 calcium phosphate compound Chemical class 0.000 abstract 1
- 235000011010 calcium phosphates Nutrition 0.000 abstract 1
- 230000006196 deacetylation Effects 0.000 abstract 1
- 238000003381 deacetylation reaction Methods 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Sustainable Development (AREA)
- Immunology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS7895 | 2005-06-14 | ||
| PCT/IS2006/000013 WO2006134614A1 (en) | 2005-06-14 | 2006-06-14 | Compositions of partially deacetylated chitin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX336736B true MX336736B (es) | 2016-01-29 |
Family
ID=36685789
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007015767A MX336736B (es) | 2005-06-14 | 2006-06-14 | Composiciones de derivados de quitina parcialmente desacetilados. |
| MX2015012065A MX375577B (es) | 2005-06-14 | 2006-06-14 | Composiciones de derivados de quitina parcialmente desacetilados. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012065A MX375577B (es) | 2005-06-14 | 2006-06-14 | Composiciones de derivados de quitina parcialmente desacetilados. |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US9078949B2 (enExample) |
| EP (1) | EP1917218B1 (enExample) |
| JP (2) | JP5632125B2 (enExample) |
| KR (1) | KR101569751B1 (enExample) |
| CN (1) | CN101248019B (enExample) |
| AU (1) | AU2006257177A1 (enExample) |
| BR (1) | BRPI0612034A2 (enExample) |
| CA (1) | CA2611453C (enExample) |
| DK (1) | DK1917218T3 (enExample) |
| HU (1) | HUE035956T2 (enExample) |
| LT (1) | LT1917218T (enExample) |
| MX (2) | MX336736B (enExample) |
| NO (2) | NO344086B1 (enExample) |
| NZ (1) | NZ565022A (enExample) |
| RU (1) | RU2421467C2 (enExample) |
| SI (1) | SI1917218T1 (enExample) |
| WO (1) | WO2006134614A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS6085A (is) * | 2001-09-26 | 2003-03-27 | Genis Ehf. | Lyfjablanda með kítósan óligómerum |
| US9034348B2 (en) | 2006-12-11 | 2015-05-19 | Chi2Gel Ltd. | Injectable chitosan mixtures forming hydrogels |
| US10201490B2 (en) | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
| EP1958639A1 (en) | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans for the treatment of nail inflammatory diseases |
| AU2009258885A1 (en) * | 2008-06-11 | 2009-12-17 | Chi2Gel Ltd. | Injectable hydrogel forming chitosan mixtures |
| CA2731201C (en) * | 2008-07-18 | 2018-10-16 | Genis Ehf. | Composition for treating autoimmune disorders |
| CN102417550B (zh) * | 2010-09-28 | 2014-04-30 | 扬州鸿信生物制品有限公司 | 一种甲壳素生产设备 |
| WO2012145626A1 (en) * | 2011-04-22 | 2012-10-26 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphylococcus vaccine |
| US10130654B2 (en) * | 2011-05-24 | 2018-11-20 | Hangli Biosciences Co., Ltd. | Method of inducing osteogensis and promoting osseointegration around an implant |
| GB201205174D0 (en) * | 2012-03-23 | 2012-05-09 | Medtrade Products Ltd | Process for producing low endotoxin chitosan |
| CN104470550A (zh) * | 2012-04-23 | 2015-03-25 | 杰尼斯公共有限公司 | 作为骨移植替代物的含有部分脱乙酰壳多糖的自硬化生物活性接合剂组合物 |
| FI2968427T3 (fi) | 2013-03-12 | 2023-03-01 | Konjugaatti sienisoluseinämän polysakkarideihin kohdentuvien vasta-aineiden indusoimiseksi | |
| GB201309606D0 (en) * | 2013-05-29 | 2013-07-10 | Medtrade Products Ltd | Process for producing low endotoxin chitosan |
| GB201309607D0 (en) * | 2013-05-29 | 2013-07-10 | Medtrade Products Ltd | Process for producing low endotoxin chitosan |
| GB2514592A (en) | 2013-05-30 | 2014-12-03 | Medtrade Products Ltd | Degradable haemostat composition |
| FR3016882A1 (fr) | 2014-01-30 | 2015-07-31 | Sofradim Production | Procede de preparation de chitosane a haut degre d’acetylation |
| JP6512630B2 (ja) * | 2015-02-26 | 2019-05-15 | オルガノ株式会社 | セレン及び／またはヒ素の濃縮方法及び分析方法並びに装置 |
| CN108114321A (zh) * | 2017-12-29 | 2018-06-05 | 广州军区广州总医院 | 一种抗骨巨细胞瘤壳聚糖-纳米羟基磷灰石支架、其制备方法及应用 |
| CN109529105A (zh) * | 2018-10-04 | 2019-03-29 | 南京航空航天大学溧水仿生产业研究院有限公司 | 仿生人工骨材料的制备方法 |
| WO2020186021A1 (en) * | 2019-03-13 | 2020-09-17 | Virginia Commonwealth University | Method for forming flexible and biodegradable structures from low molecular weight chitin biopolymers |
| US20230285442A1 (en) * | 2020-03-26 | 2023-09-14 | Subhra Mohapatra | Use of oligochitosans and derivatives thereof for neutralizing viral agents |
| JP7602224B2 (ja) * | 2020-05-15 | 2024-12-18 | 京都府公立大学法人 | 非晶性キチンを含む創傷治癒材 |
| CN111803714B (zh) * | 2020-07-29 | 2021-12-21 | 陕西科技大学 | 一种综合酸-碱溶剂体系的壳聚糖骨修复支架及其制备方法 |
| CN112341551A (zh) * | 2020-11-05 | 2021-02-09 | 广东广纳安疗科技有限公司 | 一种具有超低内毒素的壳聚糖类物质及其制备方法 |
| CN112724273B (zh) * | 2021-01-26 | 2022-02-22 | 焦点生物医药有限公司 | 一种高分子量银耳多糖的提取及制备方法 |
| EP4122961A1 (en) * | 2021-07-20 | 2023-01-25 | Westfälische Wilhelms-Universität Münster | Chitosan oligomers and uses thereof |
| AU2022417673A1 (en) * | 2021-12-20 | 2024-08-01 | Genis Hf. | Implants with bioactive coating comprising partially deacetylated chitosan |
| CN114533967B (zh) * | 2022-03-30 | 2023-01-03 | 江苏益通生物科技有限公司 | 一种脱乙酰壳聚糖神经导管及其制备方法 |
| CA3263004A1 (en) * | 2022-08-11 | 2024-02-15 | Genis Hf. | 3D PRINTED BIOACTIVE SCAFFOLDING |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2795579A (en) * | 1953-10-09 | 1957-06-11 | Warner Lambert Pharmaceutical | Process for purification of chitosan by means of the salicylic acid salt thereof |
| EP0371878A1 (fr) * | 1988-11-30 | 1990-06-06 | Rhone-Poulenc Sante | Compositions pour l'enrobage d'additifs alimentaires destinés aux ruminants |
| JP2814701B2 (ja) * | 1990-06-04 | 1998-10-27 | 味の素株式会社 | 水容性部分脱アセチル化キチンの製造法 |
| JP3181337B2 (ja) * | 1991-09-13 | 2001-07-03 | ピアス株式会社 | キトサンオリゴ糖混合物の製造方法、及びキチンオリゴ糖混合物の製造方法 |
| RU2065447C1 (ru) * | 1992-11-30 | 1996-08-20 | Владимир Петрович Голицин | Способ получения хитозана |
| KR970008132B1 (ko) * | 1993-02-08 | 1997-05-21 | 전동원 | 생체 임상의학용 키틴 및 키토산 제조방법 |
| JP3118423B2 (ja) * | 1996-08-30 | 2000-12-18 | ツヤック株式会社 | 水溶性の部分アセチル化キトサン液の製造方法 |
| JP2990248B2 (ja) * | 1997-06-18 | 1999-12-13 | 鳥取県 | 非晶質の水溶性部分脱アセチル化キチンの製造方法 |
| JPH11276189A (ja) * | 1998-03-30 | 1999-10-12 | Tottori Prefecture | 非晶質の水溶性部分脱アセチル化キチンを基質とする酵素によるオリゴ糖の製造方法 |
| US20030158302A1 (en) * | 1999-12-09 | 2003-08-21 | Cyric Chaput | Mineral-polymer hybrid composition |
| JP3653626B2 (ja) * | 2000-01-13 | 2005-06-02 | 独立行政法人科学技術振興機構 | 有機・無機交互多重積層複合体 |
| JP4669932B2 (ja) * | 2000-05-02 | 2011-04-13 | 学校法人日本大学 | 生体材料用組成物及びその硬化体 |
| US7014749B2 (en) * | 2000-12-28 | 2006-03-21 | Board Of Regents Of The University Of Nebraska | Electrolytic deposition of coatings for prosthetic metals and alloys |
| NO20015986D0 (no) * | 2001-08-02 | 2001-12-06 | Einar J Mustaparta | Produktet chitosan, samt fremstillingsmetode og anvendelse av chitosan |
| IS6085A (is) * | 2001-09-26 | 2003-03-27 | Genis Ehf. | Lyfjablanda með kítósan óligómerum |
| JP3755004B2 (ja) * | 2003-07-01 | 2006-03-15 | 独立行政法人物質・材料研究機構 | キチン誘導体−リン酸カルシウム複合体繊維とその製造方法 |
| CN1233664C (zh) * | 2003-12-23 | 2005-12-28 | 孝感学院 | 一种制备水溶性壳聚糖的方法 |
| DE202008005046U1 (de) | 2008-04-11 | 2008-07-03 | Design Ballendat Gmbh | Tisch mit verschwenkbarem Bügelfuß |
-
2006
- 2006-06-14 NZ NZ565022A patent/NZ565022A/en unknown
- 2006-06-14 CA CA2611453A patent/CA2611453C/en not_active Expired - Lifetime
- 2006-06-14 MX MX2007015767A patent/MX336736B/es unknown
- 2006-06-14 MX MX2015012065A patent/MX375577B/es unknown
- 2006-06-14 RU RU2008101385/05A patent/RU2421467C2/ru active
- 2006-06-14 WO PCT/IS2006/000013 patent/WO2006134614A1/en not_active Ceased
- 2006-06-14 HU HUE06745229A patent/HUE035956T2/en unknown
- 2006-06-14 KR KR1020087001087A patent/KR101569751B1/ko not_active Expired - Lifetime
- 2006-06-14 JP JP2008516507A patent/JP5632125B2/ja not_active Expired - Lifetime
- 2006-06-14 US US11/922,014 patent/US9078949B2/en active Active
- 2006-06-14 CN CN2006800285048A patent/CN101248019B/zh not_active Expired - Lifetime
- 2006-06-14 EP EP06745229.2A patent/EP1917218B1/en not_active Expired - Lifetime
- 2006-06-14 BR BRPI0612034-2A patent/BRPI0612034A2/pt not_active Application Discontinuation
- 2006-06-14 AU AU2006257177A patent/AU2006257177A1/en not_active Abandoned
- 2006-06-14 SI SI200632196T patent/SI1917218T1/sl unknown
- 2006-06-14 DK DK06745229.2T patent/DK1917218T3/en active
- 2006-06-14 LT LTEP06745229.2T patent/LT1917218T/lt unknown
-
2008
- 2008-01-14 NO NO20080240A patent/NO344086B1/no unknown
-
2014
- 2014-07-10 JP JP2014142045A patent/JP6293005B2/ja not_active Expired - Lifetime
-
2015
- 2015-06-11 US US14/736,984 patent/US20160002360A1/en not_active Abandoned
-
2017
- 2017-12-27 US US15/855,884 patent/US20180186899A1/en not_active Abandoned
-
2019
- 2019-07-30 NO NO20190933A patent/NO20190933A1/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US9078949B2 (en) | 2015-07-14 |
| US20180186899A1 (en) | 2018-07-05 |
| NZ565022A (en) | 2011-04-29 |
| BRPI0612034A2 (pt) | 2012-08-28 |
| KR20080036580A (ko) | 2008-04-28 |
| RU2421467C2 (ru) | 2011-06-20 |
| LT1917218T (lt) | 2017-11-27 |
| CA2611453A1 (en) | 2006-12-21 |
| US20160002360A1 (en) | 2016-01-07 |
| MX375577B (es) | 2025-03-06 |
| CA2611453C (en) | 2015-10-06 |
| SI1917218T1 (sl) | 2017-12-29 |
| NO344086B1 (no) | 2019-09-02 |
| US20090281058A1 (en) | 2009-11-12 |
| KR101569751B1 (ko) | 2015-11-19 |
| EP1917218B1 (en) | 2017-05-17 |
| CN101248019A (zh) | 2008-08-20 |
| JP2008544014A (ja) | 2008-12-04 |
| AU2006257177A1 (en) | 2006-12-21 |
| NO20080240L (no) | 2008-03-06 |
| JP6293005B2 (ja) | 2018-03-14 |
| DK1917218T3 (en) | 2017-09-11 |
| EP1917218A1 (en) | 2008-05-07 |
| JP5632125B2 (ja) | 2014-11-26 |
| NO20190933A1 (no) | 2008-03-06 |
| WO2006134614A1 (en) | 2006-12-21 |
| CN101248019B (zh) | 2012-12-26 |
| JP2014221905A (ja) | 2014-11-27 |
| RU2008101385A (ru) | 2009-07-20 |
| HUE035956T2 (en) | 2018-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX375577B (es) | Composiciones de derivados de quitina parcialmente desacetilados. | |
| Zamboni et al. | On the bacteriostatic activity of hyaluronic acid composite films | |
| WO2010123946A3 (en) | Silk fibroin hydrogels and uses thereof | |
| BRPI0517426A (pt) | composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, e, métodos para produzir um efeito anti-proliferação celular, para produzir um efeito inibitório de cdk2, e para tratar uma doença em um animal de sangue quente | |
| CY1111454T1 (el) | Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων | |
| BRPI0507236A (pt) | método para o tratamento ou profilaxia de uma condição, e, composto | |
| ATE504317T1 (de) | Resorbierbares calciumphosphatbasierendes biopolymervernetztes knochenersatzmaterial | |
| ITMI20101451A1 (it) | Idrogelo a base di acido ialuronico e suo uso in ortopedia | |
| BRPI0717156B8 (pt) | inibidores do co-transportador 2 da glicose de sódio e composição farmacêutica que os compreende | |
| EA200300097A1 (ru) | Производные имидазола | |
| Lin et al. | Photocrosslinked gelatin methacryloyl (GelMA)/hyaluronic acid methacryloyl (HAMA) composite scaffold using anthocyanidin as a photoinitiator for bone tissue regeneration | |
| EA200800798A1 (ru) | Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха | |
| Chen et al. | Fabrication of tough poly (ethylene glycol)/collagen double network hydrogels for tissue engineering | |
| BRPI0403464A (pt) | sistema de esterilização por pulverização | |
| CY1108640T1 (el) | Χρηση αντισηπτικων δραστικων ουσιων σε ρμμα οστικα τσιμεντα | |
| Dini et al. | Progress in designing therapeutic antimicrobial hydrogels targeting implant‐associated infections: paving the way for a sustainable platform applied to biomedical devices | |
| ITUA20164153A1 (it) | Composizioni polisaccaridiche impiegabili nella riparazione tissutale | |
| BR112012014263A8 (pt) | enxertos bioativos e compósitos | |
| CY1115734T1 (el) | Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη | |
| RU2010130494A (ru) | Поперечно сшитый гидрогель, содержащий активное соединение | |
| DE602006018611D1 (de) | Biomaterialien in form von fasern zur verwendung als medizinprodukt bei der behandlung von wunden, und ihr herstellungsverfahren | |
| EA201190315A1 (ru) | ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ПАКЛИТАКСЕЛЯ И ДОЦЕТАКСЕЛЯ С КОНТРОЛИРУЕМЫМ ПОД ДЕЙСТВИЕМ pH ВЫСВОБОЖДЕНИЕМ КАНЦЕРОСТАТИЧЕСКОГО АГЕНТА | |
| Gao et al. | Multifunctional injectable bioadhesive with toll-like receptor 4 and myeloid differentiation factor 2 antagonistic anti-inflammatory potential for periodontal regeneration | |
| BRPI0516363A (pt) | composição para cuidado dos cabelos e processo para preparação de uma composição | |
| EA201170369A1 (ru) | Карбоксиэтилированные полисульфаты циклодекстрина, подходящие для применения в качестве лекарственных средств |